Xerostomia Therapeutics Market
According to Intent Market Research, the Xerostomia Therapeutics Market is expected to grow from USD 0.7 billion in 2023 at a CAGR of 9.2% to touch USD 1.4 billion by 2030. The Xerostomia Therapeutics Market is dominated by key players such as GlaxoSmithKline, Colgate-Palmolive Company, Sun Pharmaceutical Industries Ltd., Pfizer Inc., Biotene (GSK), Fresenius Kabi, Cipla Inc., Bausch Health Companies Inc., EUSA Pharma, OraHealth Corporation, Mission Pharmacal Company, Hikma Pharmaceuticals PLC and Dr. Reddy–s Laboratories Ltd.